Appili Therapeutics Statistics
Total Valuation
APLIF has a market cap or net worth of 1.88 million. The enterprise value is 10.59 million.
| Market Cap | 1.88M |
| Enterprise Value | 10.59M |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 128.37M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | n/a |
| Float | 114.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.14 |
| PB Ratio | -0.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.82 |
| EV / Sales | 72.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -84.53 |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -70.02 |
| Interest Coverage | -5.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -406.02% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 50.00% |
| Weighted Average Cost of Capital (WACC) | 8.58% |
| Revenue Per Employee | 20,480 |
| Profits Per Employee | -259,987 |
| Employee Count | 7 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, APLIF has paid 59,943 in taxes.
| Income Tax | 59,943 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.20% in the last 52 weeks. The beta is 0.07, so APLIF's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -38.20% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 45.53 |
| Average Volume (20 Days) | 24,322 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APLIF had revenue of 143,362 and -1.82 million in losses. Loss per share was -0.02.
| Revenue | 143,362 |
| Gross Profit | 143,362 |
| Operating Income | -5.38M |
| Pretax Income | -1.76M |
| Net Income | -1.82M |
| EBITDA | -5.37M |
| EBIT | -5.38M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 250,328 in cash and 8.78 million in debt, with a net cash position of -8.52 million.
| Cash & Cash Equivalents | 250,328 |
| Total Debt | 8.78M |
| Net Cash | -8.52M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -11.20M |
| Book Value Per Share | -0.09 |
| Working Capital | -10.78M |
Cash Flow
In the last 12 months, operating cash flow was -124,825 and capital expenditures -504, giving a free cash flow of -125,329.
| Operating Cash Flow | -124,825 |
| Capital Expenditures | -504 |
| Free Cash Flow | -125,329 |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,755.32% |
| Pretax Margin | -1,227.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APLIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -96.63% |
| FCF Yield | -6.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLIF has an Altman Z-Score of -193.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -193.52 |
| Piotroski F-Score | 2 |